Patents by Inventor John Ullrich

John Ullrich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CENTRALIZED ORCHESTRATION OF WORKFLOW COMPONENT EXECUTIONS ACROSS SOFTWARE SERVICES
    Publication number: 20240119383
    Abstract: An orchestration system of or otherwise available to a web platform centralizes the execution of workflow components of a workflow associated with a job posting hosted by the web platform using various software services internal and/or external to the web platform. The workflow components and attributes thereof are determined based on the job posting. Domain-specific language (DSL) instructions for the various workflow components are generated. First DSL instructions are invoked by the orchestration system to cause an execution of a first workflow component of the workflow by a first software service. The orchestration system obtains an output of the first workflow component, such as values of relevant attributes, and, based on the output and in some cases information derived other than from the first workflow component, invokes next DSL instructions to cause an execution of a next workflow component of the workflow by another software service.
    Type: Application
    Filed: October 10, 2022
    Publication date: April 11, 2024
    Inventors: John Bowers, Xiqian Han, Quanzheng Long, Jacob Lucas, Russel Mommaerts, Jeremy Spencer, Hemant Tanwar, David Thrift, Adam Ullrich, Christopher Valencia
  • Indoline derivatives
    Publication number: 20070259944
    Abstract: This invention relates to substituted indoline derivative compounds which are antagonists of the progesterone receptor, their preparation and pharmaceutical utility, particularly including contraception and treatment of benign or malignant neoplastic diseases, having the general structure: wherein R1 and R2 may be single substituents or fused to form spirocyclic rings.
    Type: Application
    Filed: June 22, 2007
    Publication date: November 8, 2007
    Applicant: Wyeth
    Inventors: Andrew Fensome, Lori Miller, John Ullrich, Reinhold Bender, Puwen Zhang, Jay Wrobel, Lin Zhi, Todd Jones, James Edwards, Christopher Tegley
  • Indoline derivatives
    Publication number: 20060160882
    Abstract: This invention relates to substituted indoline derivative compounds which are antagonists of the progesterone receptor, their preparation and pharmaceutical utility, particularly including contraception and treatment of benign or malignant neoplastic diseases, having the general structure: wherein R1 and R2 may be single substituents or fused to form spirocyclic rings.
    Type: Application
    Filed: March 17, 2006
    Publication date: July 20, 2006
    Applicant: Wyeth
    Inventors: Andrew Fensome, Lori Miller, John Ullrich, Reinhold Bender, Puwen Zhang, Jay Wrobel, Lin Zhi, Todd Jones, James Edwards, Christopher Tegley
  • Substituted 2-phenyl benzofurans as estrogenic agents
    Publication number: 20060074128
    Abstract: This invention provides estrogen receptor modulators of formula 1, having the structure wherein R, R?, A, A?, X, Y, and Y are as defined in the specification, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: October 11, 2005
    Publication date: April 6, 2006
    Applicant: Wyeth
    Inventors: Christopher Miller, Michael Collini, David Kaufman, Robert Morris, Robert Singhaus, John Ullrich, Heather Harris, James Keith, Leo Albert, Rayomand Unwalla
  • Indazoles useful in treating cardiovascular diseases
    Publication number: 20060030612
    Abstract: This invention provides compounds of Formula (I) or (Ia): that are useful in the treatment or inhibition of LXR mediated diseases.
    Type: Application
    Filed: August 1, 2005
    Publication date: February 9, 2006
    Applicant: Wyeth
    Inventors: Robert Steffan, Edward Matelan, Stephen Bowen, John Ullrich, Jay Wrobel, Edouard Zamaratski, Lars Kruger, Annabel Hedemyr, Aiping Cheng, Tomas Hansson, Rayomand Unwalla, Christopher Miller, Patrik Rhonnstad
  • Quinolines useful in treating cardiovascular disease
    Publication number: 20050131014
    Abstract: This invention provides compounds of formula I that are useful in the treatment or inhibition of LXR mediated diseases.
    Type: Application
    Filed: December 10, 2004
    Publication date: June 16, 2005
    Applicant: Wyeth
    Inventors: Michael Collini, Robert Singhaus, Baihua Hu, James Jetter, Robert Morris, David Kaufman, Christopher Miller, John Ullrich, Rayomand Unwalla, Jay Wrobel, Elaine Quinet, Ponnal Nambi, Ronald Bernotas, Merle Elloso
  • Substituted 2-phenyl benzofurans as estrogenic agents
    Publication number: 20050038107
    Abstract: This invention provides estrogen receptor modulators of formula I, having the structure wherein R, R?, A, A?, X, Y, and Y are as defined in the specification, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: April 21, 2004
    Publication date: February 17, 2005
    Inventors: Christopher Miller, Michael Collini, David Kaufman, Robert Morris, Robert Singhaus, John Ullrich, Heather Harris, James Keith, Leo Albert, Rayomand Unwalla
  • Enantioselective preparation of acetylenic or olefinic substituted cycloalkenyl dihydroxybutyrates and 4-hydroxy-tetrahydro-pyran-2-ones
    Patent number: 5248830
    Abstract: Disclosed are intermediates and a process of making an anticholesterolemic compound of the formula ##STR1## the corresponding ring-opened hydroxy acids derived therefrom and pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: June 23, 1992
    Date of Patent: September 28, 1993
    Assignee: Rhone-Poulenc Rorer Pharmaceuticals Inc.
    Inventors: John Ullrich, John R. Regan